13 completed. 13 Phase 2, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 13 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Ejaculatory Dysfunction: new trials by email Literature Review of Ejaculatory Dysfunction trials Research Report on Ejaculatory Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation sildosin 4mg, dapoxetine 60mg - Premature (Early) Ejaculation | Phase 2 / Phase 3 | Completed | Benha University | 95 | 2024-03-01 | 2025-07-23 |
| Brain Networks Implicated in Lifelong Premature Ejaculation Patients Transcranial Radom Noise Stimulation, Take Dapoxetine, Comparation EEG changes between Sham Group against tRNS and Dapoxetin participants - Premature Ejaculation, Sexual Dysfunction | Phase 1 / Phase 2 | Completed | Moises Domingo | 128 | 2021-02-02 | 2023-04-12 |
| PSD502 in Subjects With Premature Ejaculation Placebo, PSD502 - Premature Ejaculation | Phase 2 | Completed | Plethora Solutions Ltd | 121 | 2018-12-26 | 2022-07-05 |
| Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients. Lidocaine 5% spray, Placebo - Lidocaine Spray | Phase 2 | Completed | Sohag University | 150 | 2018-04-20 | 2019-10-07 |
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) IX-01 400 mg, Placebo, IX-01 800 mg - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 239 | 2017-02-28 | 2019-10-07 |
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) IX-01, Placebo - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 88 | 2014-09-01 | 2020-08-17 |
| A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels Testosterone Solution 2%, Placebo Solution - Ejaculatory Dysfunction, Hypogonadism | Phase 2 | Completed | Eli Lilly and Company | 76 | 2011-08-01 | 2014-12-19 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of YHD1044 dapoxetine - Premature Ejaculation | Phase 1 / Phase 2 | Completed | Yuhan Corporation | 24 | 2011-02-01 | 2012-08-01 |
| Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature Ejaculation Clomipramine - Premature Ejaculation | Phase 2 | Completed | Symyoo | 104 | 2010-09-01 | 2012-10-03 |
| A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation GSK557296, placebo - Premature Ejaculation | Phase 2 | Completed | GlaxoSmithKline | 77 | 2009-12-23 | 2017-09-12 |
| Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation PSD502, contains a mixture of lidocaine and prilocaine, Placebo - Premature Ejaculation | Phase 2 / Phase 3 | Completed | Plethora Solutions Ltd | 256 | 2007-10-01 | 2016-09-26 |
| A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation 16448 - Premature Ejaculation | Phase 2 | Completed | GlaxoSmithKline | 18 | 2006-12-01 | 2012-03-19 |
| Exploratory Study of Pagoclone in Men With Premature Ejaculation. pagoclone - Premature Ejaculation | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 100 | 2006-07-01 | 2013-12-27 |
Premature Ejaculation (12) · Sexual Dysfunction, Physiological (3) · Coitus (1) · Erectile Dysfunction (1) · Hypogonadism (1) · Premature Birth (1) · Sexual Dysfunctions, Psychological (1)
Genital Diseases (13) · Genital Diseases, Male (13) · Male Urogenital Diseases (13) · Mental Disorders (13) · Urogenital Diseases (13) · Sexual Dysfunctions, Psychological (12) · Sexual Dysfunction, Physiological (10) · Behavior (1) · Endocrine System Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1)
Lidocaine, Prilocaine Drug Combination (2) · dapoxetine (2) · Clomipramine (1) · Lidocaine (1) · MG 50-3-1 (1) · Prilocaine (1) · Testosterone Propionate (1) · epelsiban (1) · pagoclone (1)
GlaxoSmithKline (2) · Ixchelsis Limited (2) · Plethora Solutions Ltd (2) · Benha University (1) · Eli Lilly and Company (1) · Endo USA Inc., a Keenova Therapeutics Company (1) · Moises Domingo (1) · Sohag University (1) · Symyoo (1) · Yuhan Corporation (1)
United States (7) · Egypt (2) · South Korea (2) · Australia (1) · Canada (1) · Ireland (1) · Netherlands (1) · Spain (1)
Alejandro Molina Cabeza, MD (1) · Culley Carson, MD (1) · Jed Kaminetsky, MD, BA (1) · Whan-Seok Choi, MD, PhD (1)
PMID 23937679, PMID 26158605, PMID 31351659, PMID 31351660, PMID 38224135